CELESTIAL

This is to inform you that the Board Meeting of the company which was scheduled on 30.05.2024 stand cancelled due to non-finalization of accounts

Celestial Biolabs Limited has informed the Exchange regarding Board meeting held on April 22, 2024.

This is to inform you that the Board Meeting of the company which was scheduled to be held on 06.03.2024 stand cancelled due to non-availability of Independent directors.

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 14-Nov-2022 to consider financial statements for the period ended June and September 2022

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 14-Nov-2022 to consider financial statements for the period ended June and September 2022

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 02-Sep-2022 to consider financial statements for the period ended March 2022

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 02-Sep-2022 to consider financial statements for the period ended December 2021

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 02-Sep-2022 to consider financial statements for the period ended September 2021

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 02-Sep-2022 to consider financial statements for the period ended June 2021

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 01-Sep-2022 to consider financial statements for the period ended March 2021

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 01-Sep-2022 to consider financial statements for the period ended December 2020

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 01-Sep-2022 to consider financial statements for the period ended September 2020

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 01-Sep-2022 to consider financial statements for the period ended June 2020

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 30-Aug-2022 to consider financial statements for the period ended September 2019

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 30-Aug-2022 to consider financial statements for the period ended March 2020

Celestial Biolabs Limited has informed the Exchange about Board Meeting held on 30-Aug-2022 to consider financial statements for the period ended December 2019

Celestial Biolabs Limited has informed the Exchange regarding Board meeting held on November 14, 2018.

Celestial Biolabs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2018.

Celestial Biolabs Limited has informed the Exchange regarding Board meeting held on April 10, 2018.

Celestial Biolabs Limited has informed the Exchange regarding Outcome of Board Meeting held on February 14, 2018.

Celestial Biolabs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 13, 2017.

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stock exchanges or any statutory body as may be required in this regard.

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in their Board meeting held March 14, 2016 have transacted the following business:(1) Allotted 19,28,000 equity shares of Rs.10/- each, upon conversion of 19,28,000 convertible warrants, on preferential basis to non promoter group in accordance with the SEBI Guidelines.

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in their Board Meeting held on October 22, 2015 have decided, subject to approval from shareholders, stock exchanges or any statutory body as may be required in this regard, to issue 21,00,000 convertible warrants on preferential basis to promoters & non promoter group.

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in their Board meeting held on January 22, 2015 have transacted the following business : Allotted 12,05,350 equity shares of Rs.10/- each as Sweat Equity Shares(Fourth Tranche) to Dr. A. N. Singh, Chairman and Managing Director of the Company.

Celestial Biolabs Limited has submitted to the Exchange the outcome of the Board Meeting held on January 9, 2014

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in the Board meeting held on September 03, 2012:(a) Have accepted the resignation of Dr D C Sastry as the Chairman and Director of the company with immediate effect.(b) Have appointed Dr A N Singh as the Chairman of the Company.(c) Have reconstituted the Audit Committee, Remuneration Committee and the Shareholders Grievance committee consequent to resignation of Dr D C Sastry.

Celestial Biolabs Limited has informed the Exchange that the outcome of the meeting of the Board of Directors is as follows : (1) Dr. A. N. Singh has proposed, subject to all necessary approvals, to renounce his entitlement of Sweat Equity Shares for the balance consideration amount of Rs.4.91 crores (towards the transfer of IPRs developed and owned by him to the Company) which is 60% (approx) of his total entitlement of Rs.8.17 crores; (2) To convene an Extraordinary General Meeting of the Company on April 28, 2011 to consider the following : (a) To obtain the consent of the shareholders, su

Celestial Labs Limited has informed the Exchange vide its letter dated February 26, 2010 that "The Board of Directors in their just concluded Board meeting held today have allotted 5,89,000 equity shares of Rs.10/- each as Sweat Equity Shares to Dr A N Singh, Chairman and Managing Director of the Company in lieu of compensation(part) for transfer of Intellectual property rights in accordance with SEBI Guidelines".

Celestial Labs Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 25, 2010, have transacted the following business: (1) Allotment of 22,00,000 warrants convertible into equity shares within a period of 18 months at a price of Rs.27/- per warrant in accordance with SEBI Guidelines.

Celestial Labs Limited has informed the Exchange regarding the outcome of the meeting of the Board of Directors held on November 06, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Celestial_Outcome_06112009.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange that the Board of Directors in their Board Meeting held on October 30, 2009 have transacted the following business : 1) To meet the financial requirements with regard to the expansion plans of the company, the Board has decided to make preferential issue upto 30,00,000 equity shares to Non Promoter/ Others subject to the approval of shareholders and other regulatory bodies. 2) To convene an Extraordinary General Meeting of the members for obtaining their consent for a) Changing the name of the Company from "Celestial Labs Limited" to "Celestial